SUBSCRIBE
SUBSCRIBE

BioMidwest

Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Nebraska, Ohio & Wisconsin

BioMidwest is home to manufacturing facilities, biotech, pharma and medical device companies—and BioSpace!—making the heartland a thriving hub for industry.

Major universities in the area, including the University of Chicago and Northwestern University, contribute to the industry’s success to create powerful pipelines of talent in this region.

BioMidwest is also home to state membership associations including iBIO, Indiana Health Industry Forum, IowaBio, MichBio, Missouri Biotechnology Association, Bio Nebraska, Ohio Life Sciences and BioForward Wisconsin.

FEATURED COMPANIES
NEWS FROM BIOMIDWEST
Drug Development
Global Players Making Waves in MDD, Sanfilippo syndrome and SCLC
February 24, 2022
 · 
2 min read
 · 
Kate Goodwin
BioMidwest
Newsweek’s Most Responsible Companies are BioSpace’s Best Places to Work
February 18, 2022
 · 
4 min read
 · 
Kate Goodwin
Business
Lilly Hooks Up with ImmunoGen Again for $1.7B ADC Deal
February 15, 2022
 · 
2 min read
 · 
Alex Keown
Business
Genomenon Scores $1.7M SBIR Grant to Curate Genetic Drivers of Disease
February 15, 2022
 · 
4 min read
 · 
Gail Dutton
Load More
See the latest job opportunities in BioMidwest
SEARCH JOBS
Courtesy photobyphm/Getty Images
Policy
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug Ajovy
In a patent infringement lawsuit filed against Eli Lilly, Teva Pharmaceuticals won three and lost six patents. The patent lawsuit was over Teva’s Ajovy (fremanezumab-vfrm) to prevent migraines.
August 16, 2021
 · 
3 min read
 · 
Mark Terry
Pictured: Red and white Lilly sign on building/Mic
Drug Development
Lilly’s IL-13 Inhibitor Lebrikizumab Could Be Next Big Win in Atopic Dermatitis
August 16, 2021
 · 
2 min read
 · 
Vanessa Doctor, RN
Business
BioSpace Movers & Shakers, Aug. 13
August 12, 2021
 · 
4 min read
 · 
Alex Keown
FDA
WHO Tracking 4 Omicron Subvariants while a New Antibody Gets the Nod
February 14, 2022
 · 
5 min read
 · 
Mark Terry
Drug Development
Endevica Bio Makes Cancer Scourge Cachexia Waste Away
February 8, 2022
 · 
5 min read
 · 
Gail Dutton
Yuriko Nakao/Getty Images
Drug Development
Astellas Gene Therapy for Pompe Disease Clears Important Safety Hurdle
February 8, 2022
 · 
4 min read
 · 
Alex Keown
Business
New Leaders Take the Helm at Three Biopharma Companies
February 4, 2022
 · 
3 min read
 · 
Alex Keown
Load More
MORE COMPANIES IN BIOMIDWEST
Battelle
Cingulate Therapeutics
CMIC Inc
DiaMedica Therapeutics, Inc.
Elephas
Humanetics
ImmunoPhotonics
INCOG BioPharma Services
Medexus Pharma
Northstar Medical Radiosotopes
Odyssey Therapeutics
ONL Therapeutics
Perspective Therapeutics
Sudo Biosciences
TE Connectivity
Telix Pharmaceuticals
TerSera Therapeutics
Pictured: Scales of justice swing in the air/court
Policy
Pfizer Alleges Stolen Trade Secrets at Heart of Regor Therapeutics Launch
February 3, 2022
 · 
2 min read
 · 
Alex Keown
SKYRIZI is the new option for psoriatic arthritis.
Drug Development
AbbVie Leans on Skyrizi, Rinvoq as Humira Rides off the Patent Cliff
February 2, 2022
 · 
4 min read
 · 
Mark Terry
Courtesy Microbiologics, Inc.
BioMidwest
At 50, Microbiologics is Still Setting the Standard and Inspiring Confidence in Science
February 1, 2022
 · 
6 min read
 · 
Heather McKenzie
Drug Development
The Epidemic of Obesity and its Impact on the Immune System
January 31, 2022
 · 
9 min read
 · 
Ignacio Guerrero-Ros, Ph.D. (Guest Contributor)
Load More
Interested in appearing on the Hotbed Maps?
Find out how your organization can be featured!
LEARN MORE